Hinge Health operates an advanced AI-driven platform targeting joint and muscle care inefficiencies, utilizing proprietary TrueMotion computer vision and electrical nerve stimulation wearables. The company’s historical growth, driven by multi-year contracts primarily with self-insured employers and large payers, has resulted in rapid revenue expansion but escalating net losses nearing $528 million in 2025. While its scalable software-led delivery model sharply reduces labor intensity, concentrated client dependencies and regulatory scrutiny pose execution challenges. Capital allocation prioritizes reinvestment over returns amid improving free cash flow metrics, with international expansion and new program launches defining near-term growth milestones.